Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Pietrantonio

Showing results (41-50 of 323) with videos related to

Pageof 33
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2025
MSI-H locally recurrent rectal cancer: Immune checkpoint inhibitors vs. standard chemotherapy and pelvic exenterationLuca Sorrentino, Vincenzo Nasca, Elena Daveri, et al.
Critical Reviews in Oncology/Hematology|March 6, 2022
BRAF-mutated colorectal adenocarcinomas: Pathological heterogeneity and clinical implicationsValentina Angerilli, Giovanna Sabella, Giovanni Centonze, et al.
Plos One|October 1, 2014
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studiesRoberto Iacovelli, Filippo Pietrantonio, Alessio Farcomeni, et al.
Annals of Surgical Oncology|December 23, 2017
Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective SeriesMarcello Guaglio, Snita Sinukumar, Shigeki Kusamura, et al.
Annals of Surgical Oncology|January 21, 2018
Correction to: Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective SeriesMarcello Guaglio, Snita Sinukumar, Shigeki Kusamura, et al.
Gastro Hep Advances|January 8, 2026
Efficacy and Safety of Anti-PD-(L)1 Treatments: A Systematic Review and Meta-Analysis of Asian vs Non-Asian Patients with Esophageal Squamous Cell CarcinomaJaffer Ajani, Lin Zhan, Alysha Kadva, et al.
Annals of Surgical Oncology|September 25, 2020
Prognostic Impact of Primary Side and RAS/RAF Mutations in a Surgical Series of Colorectal Cancer with Peritoneal MetastasesDario Baratti, Shigeki Kusamura, Monica Niger, et al.
International Journal of Cancer|January 8, 2019
Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trialsDominik Paul Modest, Fernando Rivera, Jean-Baptiste Bachet, et al.
Targeted Oncology|June 14, 2011
Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancerMarco Platania, Francesco Agustoni, Barbara Formisano, et al.
Critical Reviews in Oncology/Hematology|May 11, 2015
Bevacizumab-based neoadjuvant chemotherapy for colorectal cancer liver metastases: Pitfalls and helpful tricks in a review for cliniciansFilippo Pietrantonio, Armando Orlandi, Alessandro Inno, et al.
Pageof 33

Showing results (41-50 of 323) with videos related to

Sort By:
Pageof 33
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2025
MSI-H locally recurrent rectal cancer: Immune checkpoint inhibitors vs. standard chemotherapy and pelvic exenterationLuca Sorrentino, Vincenzo Nasca, Elena Daveri, et al.
Critical Reviews in Oncology/Hematology|March 6, 2022
BRAF-mutated colorectal adenocarcinomas: Pathological heterogeneity and clinical implicationsValentina Angerilli, Giovanna Sabella, Giovanni Centonze, et al.
Plos One|October 1, 2014
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studiesRoberto Iacovelli, Filippo Pietrantonio, Alessio Farcomeni, et al.
Annals of Surgical Oncology|December 23, 2017
Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective SeriesMarcello Guaglio, Snita Sinukumar, Shigeki Kusamura, et al.
Annals of Surgical Oncology|January 21, 2018
Correction to: Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective SeriesMarcello Guaglio, Snita Sinukumar, Shigeki Kusamura, et al.
Gastro Hep Advances|January 8, 2026
Efficacy and Safety of Anti-PD-(L)1 Treatments: A Systematic Review and Meta-Analysis of Asian vs Non-Asian Patients with Esophageal Squamous Cell CarcinomaJaffer Ajani, Lin Zhan, Alysha Kadva, et al.
Annals of Surgical Oncology|September 25, 2020
Prognostic Impact of Primary Side and RAS/RAF Mutations in a Surgical Series of Colorectal Cancer with Peritoneal MetastasesDario Baratti, Shigeki Kusamura, Monica Niger, et al.
International Journal of Cancer|January 8, 2019
Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trialsDominik Paul Modest, Fernando Rivera, Jean-Baptiste Bachet, et al.
Targeted Oncology|June 14, 2011
Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancerMarco Platania, Francesco Agustoni, Barbara Formisano, et al.
Critical Reviews in Oncology/Hematology|May 11, 2015
Bevacizumab-based neoadjuvant chemotherapy for colorectal cancer liver metastases: Pitfalls and helpful tricks in a review for cliniciansFilippo Pietrantonio, Armando Orlandi, Alessandro Inno, et al.
Pageof 33